|
pain
| Date |
Article Rating |
Type |
Title |
|
Apr 15, 2004 |
 |
Article,DrugNews |
New Study Results Show Benefit for Alzheimer's Disease Patients Taking Lipitor(TM)
Results of a Sun City, Arizona research study unveiled today in Montreal showed that Lipitor(TM), a cholesterol-lowering medication, slows the progression and reduces the deterioration of Alzheimer's Disease (AD). |
|
Mar 19, 2003 |
|
Article |
Researchers Discover Role of painkillers in Protecting Against Alzheimer’s
In a breakthrough study, UCLA scientists have found that common painkillers such as ibuprofen and naproxen may actually dissolve the brain lesions -- or amyloid plaques -- that are one of the definitive hallmarks of Alzheimer's disease. The findings are reported in the March 31 issue of Neuroscience.
|
|
Jan 06, 2003 |
|
Article |
Living well with Living Wills - giving people with dementia a choice in their future health care
Many people with dementia want a Living Will (sometimes called an Advance Directive) because they want to ensure that their wishes regarding their future care and treatment are taken into account. A Living Will allows a person in the early stages of Alzheimer's or another form of dementia to state what care they would like when they are no longer able to communicate effectively or understand the choices that have to be made about their care.
|
|
Sep 16, 2002 |
|
Article |
Study Finds Dental Problems Often Undetected in Nursing Home Patients with Dementia
pain resulting from tooth decay and other dental problems is often left undetected in nursing home residents suffering from dementia, reports a new study published in the July-August issue of the American Journal of Alzheimer’s Disease. The researchers believe properly identifying and treating dental pain could significantly affect the quality of life for these residents and caregivers alike.
|
|
Feb 25, 2002 |
|
Article |
Alzheimer's Disease Patients Show Improved Cognition and Global Function with Aricept
New Research shows the medication Aricept® helped maintain or improve cognition and global function in Alzheimer's disease patients who resided in nursing homes.
|
|
Feb 07, 2000 |
|
Article |
New study proves steroids are not the answer to halting Alzheimer progress
A new study extinguishes hopes that low dose steroid therapy halts the progression of Alzheimer’s disease. |
|
Apr 04, 2006 |
|
Abstract |
Abstract: Increased Expression of N-Methyl-D-Aspartate Receptor Subunit 2D in the Skin of Patients with Fibromyalgia
Researchers studied the expression of N-methyl-D-aspartate receptors (NMDAR) in skin of patients with fibromyalgia (FM) to investigate their role. |
|
Oct 05, 2005 |
|
Article |
A New Analysis of a Standard Brain Test May Help Predict Dementia
Although Alzheimer's disease affects millions of people worldwide, there is no way to identify this devastating brain disease at its earliest stages when there still may be time to delay or even prevent the downward spiral into dementia. |
|
Aug 29, 2005 |
|
Article |
New Noninvasive Dye Could Offer Early Test for Alzheimer's
MIT scientists have developed a new dye that could offer noninvasive early diagnosis of Alzheimer's disease, a discovery that could aid in monitoring the progression of the disease and in studying the efficacy of new treatments to stop it. |
|
Jul 22, 2004 |
|
Article,DrugNews |
Study Examines SEROQUEL for the Treatment of Agitation in Elderly Patients with Dementia
Study Results Suggest SEROQUEL May Reduce Symptoms of Agitation Associated With Dementia in Long-Term Care Patients; Analysis Shows No Evidence of an Increased Risk of Cerebrovascular Adverse Events. |
|
|
Next 10 Articles>> |
|
|
|
